KuCoin Labs Invests in Dovi, a Bitcoin L2 Solution, to Further Advance the Development of BTC Ecosystem
VICTORIA, Seychelles–(BUSINESS WIRE)–#blockchain—KuCoin Labs, the incubator and investment arm of the KuCoin ecosystem, has once again demonstrated... Read more.
Ferring and PharmaBiome Enter Into a New Microbiome R&D Collaboration and Exclusive Licensing Agreement
Collaboration leverages the proven development and commercial capability of Ferring with PharmaBiome’s compelling technology to research, develop and manufacture... Read more.
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
SAR443579/IPH6101, ANKET® platform lead asset, is a first-in-class NKp46/CD16-based NK cell engager targeting CD123 from a joint research collaboration between... Read more.
ASE Technology Holding Co., Ltd Receives Industry Leadership Recognition on the Dow Jones Sustainability Indices for the Eighth Year in a Row
The only semiconductor company in the world to secure the highest ESG scores in the Semiconductor and Semi Equipment Industry Group KAOHSIUNG, Taiwan–(BUSINESS... Read more.
Bristol Myers Squibb Presents New Data at ASH 2023 Demonstrating Clinical Benefit Across B-cell Malignancies with Breyanzi as a Second-Line Treatment in High-Risk Follicular Lymphoma and in Relapsed or Refractory Chronic Lymphocytic Leukemia
In TRANSCEND FL, 95.7% of patients with high-risk relapsed or refractory follicular lymphoma (FL) treated with Breyanzi in the second-line setting achieved a complete... Read more.
Mitsubishi Electric and TXOne Networks to Cooperate in Mutual Expansion of OT Security Businesses
TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation and TXOne Networks Inc. announced today that they have signed a long-term cooperation agreement... Read more.
Boosting Business Acumen: Chicago Booth’s Executive Education Program in Finance Workshop for Non-Financial Leaders–Available in Hong Kong and Chicago
CHICAGO–(BUSINESS WIRE)–#ChicagoBoothExecEd–The University of Chicago Booth School of Business introduces The Chicago Booth Approach to Finance... Read more.
New Operation HOPE Research Finds That Financial Literacy Resources, Tools & Coaching Services Are Key Drivers of Optimism Despite Uncertain Economic Times
More than 3,500 HOPE Clients Responded to First-Ever Operation HOPE-Backed Survey, Providing Key Insights into a Broad Cross Section of American Financial Sentiment... Read more.
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis
Data demonstrated effective control of intravascular and extravascular hemolysis through 48 weeks Results showed increase in mean hemoglobin levels were maintained... Read more.
MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
Pelabresib and ruxolitinib combination significantly reduced spleen size, with an SVR35 response rate nearly double that of placebo plus ruxolitinib Showed a strong... Read more.